Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 8/20 | 0.39 |
| ▸ | ACACA | Q13085 | 8/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12115813 | 1.00 | ACACB (0.39) | ACACBACACASLC6A3SCN9AAVPR1A | |
| SCHEMBL18971252 | 0.93 | ABL1 (0.41) | ACACBACACASLC6A3 | |
| SCHEMBL12115868 | 0.93 | ABL1 (0.41) | ACACBACACASLC6A3 | |
| SCHEMBL12115867 | 0.89 | ABL1 (0.39) | ACACBACACASLC6A3 | |
| SCHEMBL18971246 | 0.89 | ABL1 (0.39) | ACACBACACASLC6A3 | |
| SCHEMBL18971675 | 0.89 | ABL1 (0.40) | ACACBACACASLC6A3 | |
| SCHEMBL12115948 | 0.89 | ABL1 (0.40) | ACACBACACASLC6A3 | |
| SCHEMBL12115815 | 0.88 | SLC6A3 (0.42) | ACACBACACASLC6A3 | |
| SCHEMBL18971334 | 0.88 | SLC6A3 (0.42) | ACACBACACASLC6A3 | |
| SCHEMBL18971731 | 0.88 | SLC6A3 (0.36) | SLC6A3CNR1ESR1ESR2AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155645-B1 | HERBICIDALLY ACTIVE BICYCLIC 1,3-DIONE COMPOUNDS | SYNGENTA LTD (GB) | 2017-06-14 | — | — | EP | disclosed |